Stock Taper
IART
INTEGRA LIFESCIENCES HOLDINGS CORPORATION
NASDAQ
$16.89
▲ UP 0.24% (0.04)

KEY STATISTICS

Market Cap$1.31 B
52w High$20.49
52w Low$8.70
Dividend Yield
Frequency
P/E7.16
Volume776.24K
Shares Out.77.77M

COMPANY

LEADERSHIP

Stuart Essig
CHIEF EXECUTIVE
Stuart Essig

COMPENSATION 2026

Salary$42,308
Stock Awards$0
Incentive Plan Pay$0
All Other Comp.$240,372
Total$282,679

ABOUT

SECTOR
Healthcare
WENT PUBLIC
August 16, 1995
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
4,427

PRICE TARGET

Target High$25.00
Target Low$19.00
Target Median$19.00
Target Consensus$20.50

UPCOMING EARNINGS

DateOct 29, 2026
DayThursday
Rev. Est.$416.30M
OCT
29
THU

SPLIT RECORD

DATETYPERATIO
2017-01-04Forward2:1
2015-07-01Forward553:500
1998-05-26Reverse1:2

PRICE

$16.89 ▲ UP 0.24% (+$0.04)
OVERLAYS
$16.95$17.10$17.259:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM16.89

About Integra LifeSciences Holdings Corporation

https://www.integralife.com ↗

Integra LifeSciences develops and markets surgical implants, instruments, and regenerative products for neurosurgery, reconstruction, and general surgery worldwide through direct sales and distribution channels.

INDUSTRY

Medical - Devices

A PRODUCT INTEGRA LIFESCIENCES HOLDINGS CORPORATION IS KNOWN FOR

CUSA® Clarity Ultrasonic Surgical Aspirator System
CUSA® Clarity Ultrasonic Surgical Aspirator System

Integra's advanced ultrasonic surgical system, FDA-cleared in November 2025 for cardiac surgeries, enables precise tissue fragmentation, emulsification, and aspiration, showcasing its innovative focus in complex surgical procedures.

Revenue by Products

IconPRODUCTQ1-2025Q2-2025Q3-2025Q4-2025
Codman Specialty Surgical$280.66M $303.96M $292.58M $323.31M
Tissue Technologies$101.99M $111.65M $109.48M $111.62M

Revenue by Geography

MapREGIONQ3-2025Q4-2025Q1-2026Q2-2026
UNITED STATES$295.85M $320.37M $289.38M $307.1M
Asia Pacific$42.68M $53.73M $45.21M $48.7M
Europe$42.89M $41.85M $39.96M $42.57M
Rest of the World$20.64M $18.96M $17.36M $20.39M

RATINGS SNAPSHOT

Overall rating: C+

DCFROEROAD/EP/EP/B
Discounted Cash Flow5
Return On Equity1
Return On Assets1
Debt To Equity1
Price To Earnings1
Price To Book4
Overall Score2

TRADES BY CONGRESS

HOUSE TRADES
Josh Gottheimer
Josh Gottheimer
Sale
2024-06-18
Gilbert Cisneros
Gilbert Cisneros
Purchase
2020-03-10
Donna Shalala
Donna Shalala
Sale (Full)
2019-01-09
SENATE TRADES
Thom Tillis
Thom Tillis
Sale (Full)
2015-02-13

INSIDER TRADES

OFFICER: SVP, FIN & PRINC ACCT OFFICER
Mosebrook Jeffrey
Sale · 937 shares
2026-07-01
OFFICER: EVP & PRESIDENT, SS
Singh Harvinder
Purchase · 5.6K shares
2026-07-01
OFFICER: EVP & PRESIDENT, TR&DT
DAVIS ROBERT T. JR.
Purchase · 11.2K shares
2026-07-01
OFFICER: EVP & CHIEF FINANCIAL OFFICER
Knight Lea Daniels
Sale · 5.2K shares
2026-07-03

MOST RECENT ANALYST GRADES

GRADE SUMMARY
HOLD 2
EQUAL WEIGHT 1
NEUTRAL 1
UNDERWEIGHT 1
5 GRADES IN THE LAST 12 MONTHS

SECTORS PEERS

PEERPRICE
BFLY$8.43COMPARE
FTRE$18.81COMPARE
SEPN$38.91COMPARE
BCAX$23.43COMPARE
TNDM$21.43COMPARE
MRVI$7.68COMPARE
INMD$14.85COMPARE
PACB$1.40COMPARE